Research-Grade Long R3 Insulin-Like Growth Factor-1Tagline: Cell Growth & Regeneration Research
IGF-1 LR3 (Long Arg3 Insulin-Like Growth Factor-1) is a synthetic, recombinant analog of human IGF-1 engineered for enhanced stability and bioactivity. The substitution of arginine for glutamic acid at position 3 and an extended 13-amino-acid N-terminal sequence prevent binding to IGF-binding proteins, significantly increasing its biological half-life.
Researchers use IGF-1 LR3 Peptide in cellular growth, muscle regeneration, metabolic, and neuroprotective studies, where it mimics the anabolic actions of insulin-like growth factor-1 while offering longer receptor interaction time and increased potency.
For Laboratory and Scientific Research Use Only. Not for Human Consumption.
Extended Half-Life: Modified structure prevents binding to IGFBPs, extending activity duration.
Cellular Growth & Regeneration: Stimulates myoblast proliferation, differentiation, and repair.
Insulin-Mimetic & Metabolic Effects: Activates PI3K/Akt pathway for nutrient uptake and cell survival.
Neuroprotective Research Applications: Studied in models of neurodegeneration and ischemia.
High Purity: ≥98% verified via HPLC and mass spectrometry.
For laboratory and scientific research only. Not for human consumption, diagnostic, or therapeutic use.